SRFF Represents Medovex Corp. In $1.3 Million Private Placement
Press Release – New York, NY – August 23, 2016 – Securities and Corporate law firm Sichenzia Ross Friedman Ference is pleased to announce that the firm has represented Medovex Corp. (NASDAQ-MDVX), a medical products manufacturer in a private placement of units consisting of 1,083,333 shares of common stock and 541,667 warrants to purchase common stock at a fixed price of $1.20 per unit without a placement agent resulting in gross proceeds of $1,560,000.
Sorrento Therapeutics Inc. acted as the lead investor in the private placement. The Sichenzia Ross Friedman Ference LLP team was led by Partners Harvey Kesner and Arthur Marcus.
Visit SRFK's LinkedIn page
Latest posts by Sichenzia Ross Ference Kesner LLP (see all)
- Sichenzia Ross Ference Kesner LLP Represents ThinkEquity, a Division of Fordham Financial Management as Sole Book-Running Manager on $18 Million Public Offering of Securities of Trovagene, Inc. - June 12, 2018
- 33/34 Act, M & A Corporate Associate - June 11, 2018
- Partner Marc J. Ross Presents Webinar on Cannabis, “Weeding Out the Confusion In Marijuana Law” - June 7, 2018